Industry: Chemical & Material
Published Date: 2025-07-03
Pages: 85 Pages
Report ld: 4781788
Request Sample
Customized Report
Polystyrene Latex Particles for Diagnostic Reagents Market Size(US$)

CAGR 2025-2031
6.7%
Market Size,2031
USD 129
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Polystyrene Latex Particles for Diagnostic Reagents was estimated to be worth US$ 82.0 million in 2024 and is forecast to a readjusted size of US$ 129 million by 2031 with a CAGR of 6.7% during the forecast period 2025-2031.
Polystyrene latex particles for diagnostic reagents are uniform, spherical polymer beads tailored for use in immunoassays, flow cytometry, and other biomedical diagnostic platforms. These microparticles, typically ranging from nanometers to microns in diameter, serve as carriers for antibodies, antigens, or other biomolecules, facilitating sensitive detection through agglutination, fluorescence, or light scattering methods. Their surfaces can be chemically modified with functional groups such as carboxyl or amino groups to enable covalent attachment of diagnostic molecules, enhancing assay specificity and sensitivity. Due to their excellent monodispersity, stability, and biocompatibility, polystyrene latex particles are essential components in a wide range of in vitro diagnostic (IVD) tests, including infectious disease screening, cancer markers, and hormone level analysis. Manufacturers also offer customized particle sizes and surface chemistries to meet the precise needs of different diagnostic platforms.
North American market for Polystyrene Latex Particles for Diagnostic Reagents was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Polystyrene Latex Particles for Diagnostic Reagents was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Polystyrene Latex Particles for Diagnostic Reagents was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key companies of Polystyrene Latex Particles for Diagnostic Reagents include Fujikura Kasei, JSR Life Sciences, Agilent Technologies, CD Bioparticles, Nanocs Inc., Polysciences, Applied Physics, Thermo Fisher Scientific, EPRUI Biotech, Vdo Biotech, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Polystyrene Latex Particles for Diagnostic Reagents, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Polystyrene Latex Particles for Diagnostic Reagents by region & country, by Type, and by Application.
The Polystyrene Latex Particles for Diagnostic Reagents market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Polystyrene Latex Particles for Diagnostic Reagents.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Polystyrene Latex Particles for Diagnostic Reagents company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Polystyrene Latex Particles for Diagnostic Reagents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Polystyrene Latex Particles for Diagnostic Reagents in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Polystyrene Latex Particles for Diagnostic Reagents Product Introduction
1.2 Global Polystyrene Latex Particles for Diagnostic Reagents Market Size Forecast (2020-2031)
1.3 Polystyrene Latex Particles for Diagnostic Reagents Market Trends & Drivers
1.3.1 Polystyrene Latex Particles for Diagnostic Reagents Industry Trends
1.3.2 Polystyrene Latex Particles for Diagnostic Reagents Market Drivers & Opportunity
1.3.3 Polystyrene Latex Particles for Diagnostic Reagents Market Challenges
1.3.4 Polystyrene Latex Particles for Diagnostic Reagents Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Polystyrene Latex Particles for Diagnostic Reagents Players Revenue Ranking (2024)
2.2 Global Polystyrene Latex Particles for Diagnostic Reagents Revenue by Company (2020-2025)
2.3 Key Companies Polystyrene Latex Particles for Diagnostic Reagents Manufacturing Base Distribution and Headquarters
2.4 Key Companies Polystyrene Latex Particles for Diagnostic Reagents Product Offered
2.5 Key Companies Time to Begin Mass Production of Polystyrene Latex Particles for Diagnostic Reagents
2.6 Polystyrene Latex Particles for Diagnostic Reagents Market Competitive Analysis
2.6.1 Polystyrene Latex Particles for Diagnostic Reagents Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Polystyrene Latex Particles for Diagnostic Reagents Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polystyrene Latex Particles for Diagnostic Reagents as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Nanoscale
3.1.2 Microscale
3.2 Global Polystyrene Latex Particles for Diagnostic Reagents Sales Value by Type
3.2.1 Global Polystyrene Latex Particles for Diagnostic Reagents Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Polystyrene Latex Particles for Diagnostic Reagents Sales Value, by Type (2020-2031)
3.2.3 Global Polystyrene Latex Particles for Diagnostic Reagents Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Direct Sales
4.1.2 Indirect Sales
4.2 Global Polystyrene Latex Particles for Diagnostic Reagents Sales Value by Application
4.2.1 Global Polystyrene Latex Particles for Diagnostic Reagents Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Polystyrene Latex Particles for Diagnostic Reagents Sales Value, by Application (2020-2031)
4.2.3 Global Polystyrene Latex Particles for Diagnostic Reagents Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
5.1 Global Polystyrene Latex Particles for Diagnostic Reagents Sales Value by Region
5.1.1 Global Polystyrene Latex Particles for Diagnostic Reagents Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Polystyrene Latex Particles for Diagnostic Reagents Sales Value by Region (2020-2025)
5.1.3 Global Polystyrene Latex Particles for Diagnostic Reagents Sales Value by Region (2026-2031)
5.1.4 Global Polystyrene Latex Particles for Diagnostic Reagents Sales Value by Region (%), (2020-2031)
5.2 North America
5.2.1 North America Polystyrene Latex Particles for Diagnostic Reagents Sales Value, 2020-2031
5.2.2 North America Polystyrene Latex Particles for Diagnostic Reagents Sales Value by Country (%), 2024 VS 2031
5.3 Europe
5.3.1 Europe Polystyrene Latex Particles for Diagnostic Reagents Sales Value, 2020-2031
5.3.2 Europe Polystyrene Latex Particles for Diagnostic Reagents Sales Value by Country (%), 2024 VS 2031
5.4 Asia Pacific
5.4.1 Asia Pacific Polystyrene Latex Particles for Diagnostic Reagents Sales Value, 2020-2031
5.4.2 Asia Pacific Polystyrene Latex Particles for Diagnostic Reagents Sales Value by Region (%), 2024 VS 2031
5.5 South America
5.5.1 South America Polystyrene Latex Particles for Diagnostic Reagents Sales Value, 2020-2031
5.5.2 South America Polystyrene Latex Particles for Diagnostic Reagents Sales Value by Country (%), 2024 VS 2031
5.6 Middle East & Africa
5.6.1 Middle East & Africa Polystyrene Latex Particles for Diagnostic Reagents Sales Value, 2020-2031
5.6.2 Middle East & Africa Polystyrene Latex Particles for Diagnostic Reagents Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Polystyrene Latex Particles for Diagnostic Reagents Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Polystyrene Latex Particles for Diagnostic Reagents Sales Value, 2020-2031
6.3 United States
6.3.1 United States Polystyrene Latex Particles for Diagnostic Reagents Sales Value, 2020-2031
6.3.2 United States Polystyrene Latex Particles for Diagnostic Reagents Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Polystyrene Latex Particles for Diagnostic Reagents Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Polystyrene Latex Particles for Diagnostic Reagents Sales Value, 2020-2031
6.4.2 Europe Polystyrene Latex Particles for Diagnostic Reagents Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Polystyrene Latex Particles for Diagnostic Reagents Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Polystyrene Latex Particles for Diagnostic Reagents Sales Value, 2020-2031
6.5.2 China Polystyrene Latex Particles for Diagnostic Reagents Sales Value by Type (%), 2024 VS 2031
6.5.3 China Polystyrene Latex Particles for Diagnostic Reagents Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Polystyrene Latex Particles for Diagnostic Reagents Sales Value, 2020-2031
6.6.2 Japan Polystyrene Latex Particles for Diagnostic Reagents Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Polystyrene Latex Particles for Diagnostic Reagents Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Polystyrene Latex Particles for Diagnostic Reagents Sales Value, 2020-2031
6.7.2 South Korea Polystyrene Latex Particles for Diagnostic Reagents Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Polystyrene Latex Particles for Diagnostic Reagents Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Polystyrene Latex Particles for Diagnostic Reagents Sales Value, 2020-2031
6.8.2 Southeast Asia Polystyrene Latex Particles for Diagnostic Reagents Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Polystyrene Latex Particles for Diagnostic Reagents Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Polystyrene Latex Particles for Diagnostic Reagents Sales Value, 2020-2031
6.9.2 India Polystyrene Latex Particles for Diagnostic Reagents Sales Value by Type (%), 2024 VS 2031
6.9.3 India Polystyrene Latex Particles for Diagnostic Reagents Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Fujikura Kasei
7.1.1 Fujikura Kasei Profile
7.1.2 Fujikura Kasei Main Business
7.1.3 Fujikura Kasei Polystyrene Latex Particles for Diagnostic Reagents Products, Services and Solutions
7.1.4 Fujikura Kasei Polystyrene Latex Particles for Diagnostic Reagents Revenue (US$ Million) & (2020-2025)
7.1.5 Fujikura Kasei Recent Developments
7.2 JSR Life Sciences
7.2.1 JSR Life Sciences Profile
7.2.2 JSR Life Sciences Main Business
7.2.3 JSR Life Sciences Polystyrene Latex Particles for Diagnostic Reagents Products, Services and Solutions
7.2.4 JSR Life Sciences Polystyrene Latex Particles for Diagnostic Reagents Revenue (US$ Million) & (2020-2025)
7.2.5 JSR Life Sciences Recent Developments
7.3 Agilent Technologies
7.3.1 Agilent Technologies Profile
7.3.2 Agilent Technologies Main Business
7.3.3 Agilent Technologies Polystyrene Latex Particles for Diagnostic Reagents Products, Services and Solutions
7.3.4 Agilent Technologies Polystyrene Latex Particles for Diagnostic Reagents Revenue (US$ Million) & (2020-2025)
7.3.5 Agilent Technologies Recent Developments
7.4 CD Bioparticles
7.4.1 CD Bioparticles Profile
7.4.2 CD Bioparticles Main Business
7.4.3 CD Bioparticles Polystyrene Latex Particles for Diagnostic Reagents Products, Services and Solutions
7.4.4 CD Bioparticles Polystyrene Latex Particles for Diagnostic Reagents Revenue (US$ Million) & (2020-2025)
7.4.5 CD Bioparticles Recent Developments
7.5 Nanocs Inc.
7.5.1 Nanocs Inc. Profile
7.5.2 Nanocs Inc. Main Business
7.5.3 Nanocs Inc. Polystyrene Latex Particles for Diagnostic Reagents Products, Services and Solutions
7.5.4 Nanocs Inc. Polystyrene Latex Particles for Diagnostic Reagents Revenue (US$ Million) & (2020-2025)
7.5.5 Nanocs Inc. Recent Developments
7.6 Polysciences
7.6.1 Polysciences Profile
7.6.2 Polysciences Main Business
7.6.3 Polysciences Polystyrene Latex Particles for Diagnostic Reagents Products, Services and Solutions
7.6.4 Polysciences Polystyrene Latex Particles for Diagnostic Reagents Revenue (US$ Million) & (2020-2025)
7.6.5 Polysciences Recent Developments
7.7 Applied Physics
7.7.1 Applied Physics Profile
7.7.2 Applied Physics Main Business
7.7.3 Applied Physics Polystyrene Latex Particles for Diagnostic Reagents Products, Services and Solutions
7.7.4 Applied Physics Polystyrene Latex Particles for Diagnostic Reagents Revenue (US$ Million) & (2020-2025)
7.7.5 Applied Physics Recent Developments
7.8 Thermo Fisher Scientific
7.8.1 Thermo Fisher Scientific Profile
7.8.2 Thermo Fisher Scientific Main Business
7.8.3 Thermo Fisher Scientific Polystyrene Latex Particles for Diagnostic Reagents Products, Services and Solutions
7.8.4 Thermo Fisher Scientific Polystyrene Latex Particles for Diagnostic Reagents Revenue (US$ Million) & (2020-2025)
7.8.5 Thermo Fisher Scientific Recent Developments
7.9 EPRUI Biotech
7.9.1 EPRUI Biotech Profile
7.9.2 EPRUI Biotech Main Business
7.9.3 EPRUI Biotech Polystyrene Latex Particles for Diagnostic Reagents Products, Services and Solutions
7.9.4 EPRUI Biotech Polystyrene Latex Particles for Diagnostic Reagents Revenue (US$ Million) & (2020-2025)
7.9.5 EPRUI Biotech Recent Developments
7.10 Vdo Biotech
7.10.1 Vdo Biotech Profile
7.10.2 Vdo Biotech Main Business
7.10.3 Vdo Biotech Polystyrene Latex Particles for Diagnostic Reagents Products, Services and Solutions
7.10.4 Vdo Biotech Polystyrene Latex Particles for Diagnostic Reagents Revenue (US$ Million) & (2020-2025)
7.10.5 Vdo Biotech Recent Developments
8 Industry Chain Analysis
8.1 Polystyrene Latex Particles for Diagnostic Reagents Industrial Chain
8.2 Polystyrene Latex Particles for Diagnostic Reagents Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Polystyrene Latex Particles for Diagnostic Reagents Sales Model
8.5.2 Sales Channel
8.5.3 Polystyrene Latex Particles for Diagnostic Reagents Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Polystyrene Latex Particles for Diagnostic Reagents market is projected to grow from US$ 87.5 million in 2025 to US$ 137 million by 2032, at a CAGR of 6.7% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-12
Pages: 125
USD 4900.00
(Single User License)
The global Polystyrene Latex Particles for Diagnostic Reagents market size was US$ 87.5 million in 2025 and is forecast to reach a readjusted size of US$ 137 million by 2032 with a CAGR of 6.7% during the forecast period 2026-2032.
Published Date: 2026-03-12
Pages: 77
USD 4250.00
(Single User License)
The global Polystyrene Latex Particles for Diagnostic Reagents market was valued at US$ 87.5 million in 2025 and is anticipated to reach US$ 137 million by 2032, at a CAGR of 6.7% from 2026 to 2032.
Published Date: 2026-03-12
Pages: 108
USD 2900.00
(Single User License)
The global market for Polystyrene Latex Particles for Diagnostic Reagents was estimated to be worth US$ 87.5 million in 2025 and is projected to reach US$ 137 million, growing at a CAGR of 6.7% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 99
USD 3950.00
(Single User License)
The global market for Polystyrene Latex Particles for Diagnostic Reagents was valued at US$ 82.0 million in the year 2024 and is projected to reach a revised size of US$ 129 million by 2031, growing at a CAGR of 6.7% during the forecast period.
Published Date: 2025-07-03
Pages: 78
USD 2900.00
(Single User License)
The global Polystyrene Latex Particles for Diagnostic Reagents market is projected to grow from US$ 87.5 million in 2025 to US$ 129 million by 2031, at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period.
Published Date: 2025-07-03
Pages: 128
USD 4900.00
(Single User License)
The global Polystyrene Latex Particles for Diagnostic Reagents market size was US$ 82.0 million in 2024 and is forecast to a readjusted size of US$ 129 million by 2031 with a CAGR of 6.7% during the forecast period 2025-2031.
Published Date: 2025-07-03
Pages: 78
USD 4250.00
(Single User License)
The global Polystyrene Latex Particles for Diagnostic Reagents market is projected to grow from US$ 87.5 million in 2025 to US$ 137 million by 2032, at a CAGR of 6.7% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-12
Pages: 125
The global Polystyrene Latex Particles for Diagnostic Reagents market size was US$ 87.5 million in 2025 and is forecast to reach a readjusted size of US$ 137 million by 2032 with a CAGR of 6.7% during the forecast period 2026-2032.
Published: 2026-03-12
Pages: 77
The global Polystyrene Latex Particles for Diagnostic Reagents market was valued at US$ 87.5 million in 2025 and is anticipated to reach US$ 137 million by 2032, at a CAGR of 6.7% from 2026 to 2032.
Published: 2026-03-12
Pages: 108
The global market for Polystyrene Latex Particles for Diagnostic Reagents was estimated to be worth US$ 87.5 million in 2025 and is projected to reach US$ 137 million, growing at a CAGR of 6.7% from 2026 to 2032.
Published: 2026-03-09
Pages: 99
The global market for Polystyrene Latex Particles for Diagnostic Reagents was valued at US$ 82.0 million in the year 2024 and is projected to reach a revised size of US$ 129 million by 2031, growing at a CAGR of 6.7% during the forecast period.
Published: 2025-07-03
Pages: 78
The global Polystyrene Latex Particles for Diagnostic Reagents market is projected to grow from US$ 87.5 million in 2025 to US$ 129 million by 2031, at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period.
Published: 2025-07-03
Pages: 128
The global Polystyrene Latex Particles for Diagnostic Reagents market size was US$ 82.0 million in 2024 and is forecast to a readjusted size of US$ 129 million by 2031 with a CAGR of 6.7% during the forecast period 2025-2031.
Published: 2025-07-03
Pages: 78
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now